Fact-checked by Grok 2 weeks ago

Decompensation

Decompensation refers to the functional deterioration of a physiological or psychological system that was previously maintained through compensatory mechanisms, resulting in an acute worsening of clinical status or mental functioning. In medical contexts, it commonly describes scenarios where organs or systems fail to sustain , such as in , where (ADHF) involves the rapid onset or exacerbation of symptoms like , fluid retention, and reduced , often requiring urgent . Similarly, in , decompensated manifests as a sudden decline in liver function, characterized by , , , and variceal bleeding, marking a transition from compensated to advanced-stage with poor . This physiological increases short-term risks of or severe harm, frequently triggered by infections, non-adherence, or stressors on the system. In and , decompensation denotes a in an individual's mechanisms, leading to progressive loss of normal functioning, worsening of psychiatric symptoms, or episodes of acute mental deterioration such as intensified anxiety, delusions, or depressive states. Such psychological decompensation often occurs under excessive stress, , or in chronic mental illnesses like or , where coping strategies fail, potentially resulting in hospitalization or significant impairment. Across both domains, early recognition of decompensation is critical for interventions that aim to restore compensation and prevent irreversible damage.

Etymology and History

Origin of the Term

The term "decompensation" originates from the Latin prefix de-, denoting , removal, or intensification in the negative sense, combined with "compensation," derived from the Latin verb compensare, meaning "to weigh together," "balance," or "offset" by counterbalancing elements. This etymological structure reflects the concept of a breakdown or failure in previously established balancing mechanisms, initially applied in scientific and medical contexts to describe systemic imbalances. The noun "decompensation" first entered English medical lexicon in 1905, as documented in George M. Gould's A Dictionary of New Medical Terms, where it was introduced to denote the deterioration or failure of physiological structures that had previously functioned through adaptive compensation. Gould's entry marked the term's formal coinage in a comprehensive medical reference, emphasizing its relevance to bodily processes unable to sustain equilibrium amid stress or defect. From its inception, "decompensation" became closely associated with , specifically referring to the heart's loss of compensatory adaptations—such as increased or —that temporarily offset underlying impairments to maintain circulation. This early cardiac linkage underscored the term's utility in describing the transition from compensated to overt failure states in cardiovascular medicine.

Historical Development

The term "decompensation" first appeared in in the early , primarily within , to characterize the failure of compensatory physiological mechanisms in , marking a shift from stable compensation to symptomatic deterioration such as and dyspnea. This usage built on earlier 19th-century concepts of cardiac compensation in chronic heart conditions under increasing load. By the mid-20th century, the concept expanded beyond to broader medical applications, including respiratory and hepatic systems, as documented in influential journals. The adoption of "decompensation" in occurred by the mid-20th century, drawing from Freudian theories of mechanisms that collapse under excessive , resulting in symptom . Influenced by Sigmund Freud's foundational work and expanded by Anna Freud's 1936 elaboration on defensive processes, the term described psychological breakdown where adaptive coping fails, leading to anxiety, delusions, or regression. Key mentions appeared in (APA) literature during the 1950s, notably in the first edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-I, 1952), which used it in contexts such as personality disorders to denote functional decline. Following the , decompensation became integrated into psychiatric diagnostics across editions, framing episodes of mental deterioration in conditions like and personality disorders under stressor-induced . In (1968) and subsequent revisions, it underscored the role of environmental triggers in precipitating decompensation, influencing criteria for disorders involving acute psychotic or affective episodes. This evolution paralleled the shift toward operationalized diagnostics in , emphasizing decompensation as a measurable indicator of illness progression.

Medical Decompensation

Definition and Pathophysiology

In , decompensation refers to the functional deterioration of an or physiological system that was previously maintaining through compensatory mechanisms, typically in response to or an acute insult. This failure occurs when the body's adaptive responses can no longer sustain normal function, leading to a decline in organ and potential systemic effects. The pathophysiological process begins with initial compensation, where the affected employs adaptive strategies to counteract the underlying stressor. For instance, , myocardial increases contractile mass to preserve , while in the liver, develops to structurally support tissue integrity amid ongoing injury. These mechanisms, including neurohumoral activations like the renin-angiotensin-aldosterone system (RAAS) and , initially help maintain and function but impose additional workload on the organ. Over time, however, exhaustion of these reserves—due to progressive cellular damage, excessive , or fluid overload—triggers decompensation, marked by reduced efficiency, , and onset of symptoms such as or . A key example is seen in , where the transition from a compensated, often state to decompensation arises from neurohormonal overload. Hyperactivity of the RAAS promotes and sodium retention, elevating preload and , which ultimately impairs ventricular function and precipitates acute worsening. Generally, decompensation unfolds in stages: a pre-decompensation or phase where compensatory mechanisms preserve ; the decompensation characterized by overt and symptom emergence; and, if unresolved, progression to multi-organ failure through cascading hypoperfusion and inflammatory responses.

Specific Contexts

In the cardiovascular system, decompensation frequently presents as (ADHF), a condition involving rapid worsening of symptoms due to fluid overload and reduced . Common triggers include arrhythmias such as , myocardial ischemia from acute coronary syndromes, infections, and medication non-compliance, which precipitate fluid redistribution and increased ventricular pressures. Symptoms typically include progressive , , weight gain, and with crackles on , reflecting pulmonary congestion. Key risk factors are affecting up to 72% of cases, prior ischemic heart disease in about 68%, and in approximately 45%, often compounded by older age and comorbidities. Respiratory decompensation commonly occurs in (COPD) during acute exacerbations, where airway obstruction intensifies, leading to ventilatory failure. Triggers such as bacterial or viral infections exacerbate dynamic and expiratory flow limitation, increasing and causing rapid shallow respiration. This results in from impaired CO₂ elimination and ventilation-perfusion mismatch, often progressing to with arterial pH dropping below 7.35 and PaCO₂ rising to around 55 mm Hg. Presentations include worsened dyspnea, increased production, wheezing, and accessory muscle use, with severe cases showing confusion from or ; decompensated correlates with higher short- and long-term mortality risk. In the hepatic system, decompensation in cirrhosis arises from escalating portal hypertension, transitioning patients from compensated to decompensated states with complications like ascites and variceal bleeding. Portal hypertension, measured by hepatic venous pressure gradient (HVPG) ≥10 mm Hg, drives splanchnic vasodilation and fluid leakage into the peritoneum, causing ascites as the most common initial decompensation event. Variceal bleeding emerges when HVPG reaches ≥12 mm Hg, with acute episodes at ≥20 mm Hg posing high rebleeding and mortality risks due to esophageal or gastric varices rupture. Prognostic assessment relies on the Model for End-Stage Liver Disease (MELD) score, which integrates serum bilirubin, INR, and creatinine to predict 3-month mortality and decompensation risk, with scores ≥15 indicating elevated transplant-free mortality in patients with ascites. Renal decompensation can manifest as progression of (AKI), where initial insults like or nephrotoxins lead to intrinsic renal damage and potential . Untreated prerenal AKI may evolve into , with dropping sharply and recovery taking weeks to months, increasing end-stage renal disease risk up to 28-fold in some cohorts. Neurological decompensation in trauma often involves elevated (), exceeding 20–25 mm Hg and disrupting cerebral perfusion per the Monro-Kellie doctrine. causes space-occupying lesions like hematomas, overwhelming compensatory mechanisms of and blood volume displacement, leading to herniation and ischemia. Risk escalates with <8, where refractory ICP correlates with 92% mortality.

Clinical Management

Clinical management of medical decompensation focuses on timely diagnosis, acute stabilization, long-term prevention, and prognostic assessment to improve patient outcomes across various organ systems. Diagnosis typically integrates clinical evaluation with targeted biomarkers, imaging, and standardized scoring systems to identify decompensation early and guide therapeutic decisions. In cardiac decompensation, such as acute decompensated heart failure (ADHF), B-type natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP) serves as a primary biomarker, with levels above 100 pg/mL for BNP or 300 pg/mL for NT-proBNP supporting the diagnosis in non-acute settings, and higher thresholds (e.g., BNP >500 pg/mL) indicating greater urgency in emergency presentations. is essential for imaging, providing real-time assessment of left ventricular (LVEF) and identifying structural issues like valvular dysfunction or wall motion abnormalities. The New York Heart Association (NYHA) functional classification system stratifies severity based on symptom limitation during activity: Class I (no limitation), Class II (slight limitation with ordinary activity), Class III (marked limitation with less than ordinary activity), and Class IV (symptoms at rest), aiding in and . For hepatic decompensation in , diagnosis relies on clinical signs like or , with the Child-Pugh score incorporating , , , , and to grade severity (Class A: 5-6 points, mild; Class B: 7-9, moderate; Class C: 10-15, severe). Acute prioritizes hemodynamic stabilization, of , and of , often requiring hospitalization and multidisciplinary . In ADHF, intravenous such as (initial dose 20-40 mg, titrated based on response) are first-line for , aiming to achieve euvolemia while monitoring for electrolyte imbalances. Vasodilators like infusion are recommended for patients with persistent and pulmonary to reduce preload and , targeting a systolic above 90-100 mmHg. For complicating decompensation, mechanical circulatory support including the (IABP) may be considered as a bridge to recovery or advanced therapies, though evidence from randomized trials shows no mortality benefit over medical therapy alone, leading to a IIb recommendation in guidelines. In hepatic decompensation, addresses specific complications: large-volume with replacement (8 g per liter of removed) for tense to prevent circulatory dysfunction, and vasoconstrictors like (1-2 mg every 4-6 hours) plus for to reverse renal hypoperfusion. Overall goals include optimizing oxygenation, correcting precipitants (e.g., infections), and escalating to intensive if multi-organ failure develops. Prevention strategies emphasize guideline-directed medical therapy (GDMT), lifestyle interventions, and proactive monitoring to avert recurrent episodes and slow disease progression. For patients, GDMT includes (ACE) inhibitors (e.g., lisinopril 5-40 mg daily) or angiotensin receptor-neprilysin inhibitors (e.g., sacubitril-valsartan) to reduce and remodeling, beta-blockers (e.g., 6.25-50 mg twice daily) to control , antagonists (MRAs; e.g., 12.5-50 mg daily or 25-50 mg daily) to reduce mortality and hospitalizations, and sodium-glucose cotransporter-2 inhibitors (SGLT2i; e.g., dapagliflozin 10 mg daily or empagliflozin 10 mg daily) to reduce cardiovascular death and hospitalizations regardless of status, with combined use improving survival in clinical trials. modifications such as sodium restriction (<2 g/day), daily weight monitoring (alert for >2-3 lb gain in 24 hours indicating fluid retention), and recognition of early symptoms like dyspnea are critical, with structured disease management programs reducing readmissions by 20-30%. In cirrhosis, prevention involves non-selective beta-blockers (e.g., 20-160 mg/day, titrated to 55-60 bpm) for primary prophylaxis of variceal bleeding in patients with medium/large , alongside abstinence from and vaccination against /B to mitigate etiological factors. Regular surveillance, including abdominal ultrasound every 6 months for , further supports long-term stability. Prognosis in medical decompensation varies by underlying involvement and response to , with validated factors predicting mortality and guiding decisions on advanced interventions like transplantation. In cardiac cases, LVEF below 40% is a strong adverse predictor, associated with a 60% increased risk of death compared to preserved , while predischarge NT-proBNP levels >2000 pg/mL signal higher 30-day readmission rates (up to 25%). Optimization of GDMT during admission can improve 1-year survival from approximately 70% in untreated decompensation to over 85% in adherent patients. For hepatic decompensation, the Child-Pugh Class C score correlates with a 1-year survival of 45% versus 80-90% for Class A, and median survival post-first decompensation is about 2 years, dropping to 6 months with acute-on-chronic (ACLF) Grade III. Factors like persistent (<130 mmol/L) or renal impairment further worsen outcomes, underscoring the need for early referral to specialty care.

Psychological Decompensation

Definition and Theoretical Foundations

In , decompensation refers to a in an individual's mechanisms, resulting in progressive loss of adaptive functioning and the emergence or worsening of psychiatric symptoms. This process occurs when psychological s, which normally protect the from anxiety and , become overwhelmed or ineffective, leading to a de-stabilization of mental equilibrium. The theoretical foundations of decompensation trace back to Freudian , where conceptualized defense mechanisms such as repression as unconscious strategies to manage unacceptable impulses and reduce psychic tension; failure of these mechanisms under excessive stress allows repressed material to surface, manifesting as neurotic symptoms. This idea was expanded in by in her seminal work The Ego and the Mechanisms of Defense (1936), which detailed how the ego employs a range of defenses—including , , and —to maintain , but their collapse under prolonged pressure results in decompensation and impaired reality testing. The term decompensation was adapted from early 20th-century medical usage to describe this psychological failure. Decompensation is closely related to the stress-diathesis model, which posits that an interaction between inherent vulnerabilities (such as genetic predispositions) and environmental stressors precipitates the breakdown of psychological defenses, leading to acute episodes in disorders like or . In this framework, represents baseline susceptibility, while accumulating stress exceeds coping capacity, triggering decompensation as a from compensated vulnerability to symptomatic expression. Unlike compensation, which involves adaptive strategies that build by channeling energy into constructive outlets (e.g., overachieving in one domain to offset perceived weaknesses), decompensation signifies a shift to maladaptive responses where defenses fail entirely, exacerbating dysfunction rather than mitigating it.

Causes and Triggers

Psychological decompensation often arises from internal vulnerabilities that compromise an individual's ability to maintain psychic equilibrium. Unresolved represents a key internal factor, as it perpetuates and weakens adaptive strategies, leading to a breakdown in psychological functioning when latent conflicts surface. Personality disorders, particularly (), heighten susceptibility through inherent emotional instability and heightened stress reactivity, where interpersonal stressors can precipitate decompensation by overwhelming limited regulatory capacities. Additionally, imbalances, such as serotonin dysregulation commonly observed in , contribute to underlying vulnerability by impairing mood stabilization and against stressors. External triggers frequently initiate decompensation by imposing acute demands that exceed an individual's resources. Events like bereavement or significant can destabilize psychic balance, as they evoke profound and disrupt established defense mechanisms. Experiences of , whether physical or emotional, similarly act as precipitants by reactivating vulnerability to harm and eroding trust in interpersonal safety. Substance withdrawal serves as another acute trigger, inducing severe psychological distress through neurochemical disruptions that mimic or exacerbate underlying conditions. Chronic external factors accumulate over time to erode , fostering a gradual pathway to decompensation. Ongoing socioeconomic hardships, such as persistent , generate sustained through material deprivation and , which impair regulation and increase the likelihood of . Similarly, prolonged relationship strain, including chronic conflict or , contributes by perpetuating and diminishing supportive networks essential for . As of 2025, emerging research highlights additional modern triggers, such as excessive interactions with chatbots, which can induce delusions or neurotic decompensation by blurring boundaries between human and artificial responses, particularly in vulnerable individuals. Post-pandemic studies also indicate heightened vulnerability due to prolonged global stressors like economic instability and , exacerbating decompensation risks in anxiety and depressive disorders. In specific disorders, these causes and triggers manifest distinctly. For (PTSD), re-traumatization—through exposure to reminders of the original event—can rapidly precipitate decompensation by flooding the individual with intrusive memories and hyperarousal, destabilizing prior adaptations. In anxiety disorders, cumulative exposure to stressors leading to repeated episodes builds intolerable tension, resulting in decompensation as the becomes overwhelmed. Predictive models like offer a framework for understanding decompensation as the culmination of accumulation. quantifies the multisystemic "" from repeated stressor activation, predicting psychological breakdown when adaptive physiological responses fail under prolonged burden.

Symptoms and Interventions

Psychological decompensation in contexts is characterized by acute manifestations such as severe anxiety, hallucinations, , and regressive behaviors like increased or pacing. These symptoms often arise from perceptual distortions, including misinterpretations of surroundings or heightened delusions, alongside emotional volatility ranging from overwhelming fear to flat affect. Chronic signs, in contrast, include social withdrawal and impaired reality testing, where individuals exhibit confusion, difficulty concentrating, or persistent disconnection from daily functioning. In psychiatric assessments, episodes of decompensation refer to periods of rapid deterioration, marked by exacerbations in symptoms and a temporary loss of adaptive functioning, such as challenges in maintaining relationships or performing daily activities. These episodes typically last from days to weeks, often requiring heightened like hospitalization, and are evaluated for their frequency and duration to determine severity— for instance, three or more episodes each of at least two weeks within a 12-month period can indicate substantial limitations. Interventions for psychological decompensation prioritize crisis stabilization to mitigate immediate risks, including involuntary or voluntary hospitalization for safety and symptom control, particularly when or escalates. For psychotic features, antipsychotics are commonly administered to reduce hallucinations and restore reality testing, often alongside brief crisis-oriented counseling to address acute distress. Long-term therapies focus on rebuilding coping mechanisms; (CBT) helps individuals challenge distorted thoughts and develop skills to manage anxiety and mood instability, while (DBT) targets emotion regulation to prevent impulsive or regressive responses. Prevention strategies emphasize early intervention programs that monitor warning signs like or , enabling timely adjustments to avert full episodes. Medication adherence, such as consistent use of selective serotonin reuptake inhibitors (SSRIs) for underlying or anxiety, significantly lowers risk by sustaining stability over at least one year. Building support networks through family education and community resources further bolsters , promoting ongoing engagement in and therapeutic activities to maintain adaptive functioning.

References

  1. [1]
    Defining Physiological Decompensation: An Expert Consensus and ...
    Apr 1, 2022 · The expert panel arrived at a consensus definition of physiological decompensation, “An acute worsening of a patient's clinical status that ...
  2. [2]
    decompensation - APA Dictionary of Psychology
    Apr 19, 2018 · a breakdown in an individual's defense mechanisms, resulting in progressive loss of normal functioning or worsening of psychiatric symptoms.Missing: medical | Show results with:medical
  3. [3]
    Acute Decompensated Heart Failure Update - PMC - PubMed Central
    Acute decompensated heart failure (ADHF) is the rapid onset of, or change in, symptoms and signs of HF. It can be a life-threatening condition that requires ...
  4. [4]
    Management of decompensated cirrhosis - PMC - PubMed Central
    Decompensated cirrhosis is defined as an acute deterioration in liver function in a patient with cirrhosis and is characterised by jaundice, ascites, hepatic ...
  5. [5]
    Defining Physiological Decompensation: An Expert Consensus and ...
    Apr 1, 2022 · An acute worsening of a patient's clinical status that poses a substantial increase to an individual's short-term risk of death or serious harm.
  6. [6]
    Ethical considerations of competency restoration: The risk of ...
    Jan 13, 2022 · Decompensation, or the deterioration of an individual's mental health, is not only psychologically distressing to the individual experiencing it ...Missing: definition | Show results with:definition
  7. [7]
    Decompensated heart failure - PMC - PubMed Central - NIH
    Decompensated heart failure (DHF) is defined as a clinical syndrome in which a structural or functional change in the heart leads to its inability to eject and/ ...
  8. [8]
    Compensation - Etymology, Origin & Meaning
    Late 14c. origin from Latin compensationem meaning "action of compensating," derived from compensare, combining com "with" + pensare "to weigh," meaning to ...
  9. [9]
    Decompensate - Etymology, Origin & Meaning
    Origin and history of decompensate​​ "lose the ability to maintain compensation," 1912, probably a back-formation from decompensation. Related: Decompensated; ...
  10. [10]
    decompensation, n. meanings, etymology and more | Oxford English ...
    The earliest known use of the noun decompensation is in the 1900s. OED's earliest evidence for decompensation is from 1905, in a dictionary by George Gould.Missing: origin | Show results with:origin
  11. [11]
  12. [12]
    Decompensation - Etymology, Origin & Meaning
    From Latin origin, "decompensation" means lack or loss of compensation, especially in medicine, deterioration of a structure once functioning through ...Missing: psychology | Show results with:psychology
  13. [13]
  14. [14]
    DECOMPENSATED PORTAL CIRRHOSIS: REPORT OF ONE ...
    CLINICAL FEATURES OF THE ASCITIC STAGE OF CIRRHOSIS OF THE LIVERBy Dr. SnellThe association of ascites with lesions of the liver seems to have been known.
  15. [15]
    [PDF] Diagnostic and Statistical Manual: Mental Disorders (DSM-I)
    in decompensation. Acute fluctuations in the chronic progressive course of circulatory disturbances such asxcerebral arteriosclerosis will not be diagnosed.
  16. [16]
    [PDF] Diagnostic and Statistical Manual of Mental Disorders (DSM-II)
    The DSM-II is a manual for mental disorders, listing disorders and their code numbers, and is used in mental hospitals, clinics, and office practice.
  17. [17]
    Heart Failure: Background, Etiology, Pathophysiology
    Sep 25, 2025 · Alternatively, decompensation may occur as a result of the failure or exhaustion of the compensatory mechanisms but without any change in the ...<|control11|><|separator|>
  18. [18]
    Pathophysiology of Heart Failure - CV Physiology
    These changes serve as compensatory mechanisms to help maintain cardiac output (primarily by the Frank-Starling mechanism) and arterial blood pressure (by ...
  19. [19]
    Pathophysiology of decompensated cirrhosis: Portal hypertension ...
    It has long been recognised that decompensated liver diseases express patterns of immune activation with increased white blood cell count and C-reactive protein ...
  20. [20]
    Phases of Shock - Compensatory: What Is It, Causes, and More
    The compensatory phase of shock refers to the initial stage of shock when the body is still able to compensate for the decrease in tissue perfusion.<|control11|><|separator|>
  21. [21]
    Acute decompensated heart failure - PMC - NIH
    A patient facing acute decompensation is experiencing a serious medical condition that is associated with a poor prognosis. In addition, acute decompensated ...
  22. [22]
    Pathophysiology and Therapeutic Approaches to Acute ...
    May 13, 2021 · Acute decompensated heart failure (ADHF) continues to be an entity with incompletely understood pathophysiology and limited therapeutic options.Missing: terminology | Show results with:terminology
  23. [23]
    Acute Exacerbations and Respiratory Failure in Chronic Obstructive ...
    Decreased cardiac output reduces oxygen delivery to respiratory muscles, contributing to respiratory decompensation in patients with COPD (1, 24). Pulmonary ...
  24. [24]
    COPD exacerbations · 3: Pathophysiology - PMC - PubMed Central
    The presence of decompensated hypercarbia during an acute exacerbation is an important prognostic consideration and correlates with the risk of both short and ...
  25. [25]
    Cirrhosis and portal hypertension: The importance of risk ...
    Hepatic venous pressure gradient (HVPG) measurement is the most reliable tool to estimate the severity of portal hypertension in cirrhosis.
  26. [26]
    Why do we use the model for end-stage liver disease (MELD) score?
    Nov 17, 2020 · The Model for End-stage Liver Disease (or MELD) score is used to determine patient priority for liver transplantation.
  27. [27]
    Acute Kidney Injury - StatPearls - NCBI Bookshelf - NIH
    Nov 25, 2023 · Acute tubular necrosis and other intrarenal causes are often slow to recover and can take weeks to months for complete recovery of renal ...Missing: decompensation | Show results with:decompensation
  28. [28]
    PROGRESSION OF ACUTE KIDNEY INJURY TO CHRONIC ... - NIH
    There are an increasing number of clinical suggestions that acute kidney injury (AKI) can be complicated by the onset of progressive renal disease.Missing: decompensation | Show results with:decompensation
  29. [29]
    Intracranial Pressure Monitoring - StatPearls - NCBI Bookshelf - NIH
    Jan 23, 2024 · Intracranial pressure–guided therapy has been the cornerstone in managing severe traumatic brain injury. Intracranial pressure (ICP) monitoring ...
  30. [30]
    Does intracranial pressure management hurt more than it helps in ...
    Jan 12, 2018 · Raised intracranial pressure (ICP) is particularly associated with poor TBI outcomes, prompting clinicians to monitor this parameter, using it to guide ...
  31. [31]
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
    Apr 1, 2022 · The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.Volume 145, Number 18 · Correction to · Circulation · Crossref
  32. [32]
    Classes and Stages of Heart Failure - American Heart Association
    May 21, 2025 · If you have stage C or stage D heart failure, your health care professional will give you an NYHA Functional Classification as a baseline. Then, ...Heart Failure in Children and... · Risks for and Causes of Heart...
  33. [33]
    [PDF] EASL Clinical Practice Guidelines for the management of patients ...
    The following Clinical Practice Guidelines (CPGs) represent the first CPGs on the management of decompensated cirrhosis. In this context, the panel of experts, ...
  34. [34]
    Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute ...
    Nov 11, 2018 · In the US guidelines, IABP use has been downgraded to a class IIb B recommendation based on registry data. In elective high-risk percutaneous ...
  35. [35]
    Defense Mechanisms - StatPearls - NCBI Bookshelf - NIH
    May 22, 2023 · Anna Freud defined defense mechanisms as unconscious resources used by the ego to decrease internal stress ultimately.Missing: decompensation | Show results with:decompensation
  36. [36]
    Decompensation - Medical Dictionary
    ... decompensation medical term. What does decompensation mean ... The appearance or exacerbation of a mental disorder due to failure of defense mechanisms.
  37. [37]
    Depression in Schizophrenia: Perspective in the Era of “Atypical ...
    The well-known stress-diathesis model of schizophrenia (77, 78) depicts the psychosis of schizophrenia as a final common path of neuropsychiatric decompensation ...
  38. [38]
    Compensation - APA Dictionary of Psychology
    Apr 19, 2018 · Compensation may be a conscious or unconscious process. In his classical psychoanalytic theory, Sigmund Freud described compensation as a ...
  39. [39]
    Emotional expressiveness and avoidance in narratives of ...
    ... decompensation. Our findings support the idea that most of these youth could ... unresolved trauma. Conclusion. Our results suggest that the analysis of ...
  40. [40]
    Borderline personality disorder: Stress reactivity or stress generation ...
    Our longitudinal study of a well-characterized clinical sample found more evidence for stress generation than for stress-induced decompensation in BPD.
  41. [41]
    What has serotonin to do with depression? - PMC - PubMed Central
    Jun 4, 2015 · At its simplest, the hypothesis proposes that diminished activity of serotonin pathways plays a causal role in the pathophysiology of depression ...Missing: decompensation | Show results with:decompensation
  42. [42]
    Withdrawal Syndromes - StatPearls - NCBI Bookshelf - NIH
    Sep 2, 2024 · [25] Chronic alcoholism and withdrawal are more common in men than in women.[23] The mortality rate from alcohol withdrawal and delirium tremens ...Missing: decompensation | Show results with:decompensation
  43. [43]
    Poverty and mental health: policy, practice and research implications
    Poverty is both a cause of mental health problems and a consequence. Poverty in childhood and among adults can cause poor mental health through social stresses ...Missing: decompensation | Show results with:decompensation
  44. [44]
    Poverty, depression, and anxiety: Causal evidence and mechanisms
    The stronger correlation of mental health with income suggests that mental health may be more affected by short-run changes to economic status than long-run or ...Missing: decompensation | Show results with:decompensation
  45. [45]
    Stages of decompensation in combat-related posttraumatic stress ...
    This conceptual article presents a model of severe, chronic combat-related PTSD based on several years of longitudinal clinical observations of Vietnam vet.<|control11|><|separator|>
  46. [46]
    [PDF] Chronic Stress Leads to Anxiety and Depression - JSciMed Central
    Jan 27, 2017 · Studies have found a link between chronic stress and anxiety disorders as well as major depressive disorder. This article reviews literature ...Missing: cumulative decompensation<|separator|>
  47. [47]
    Allostasis and Allostatic Load: Implications for ... - Nature
    Feb 1, 2000 · The concepts of allostasis and allostatic load center around the brain as interpreter and responder to environmental challenges and as a target of those ...
  48. [48]
    None
    Summary of each segment:
  49. [49]
    A Consideration for Cost-Effective Treatment of Severe Mental Illness
    Clinicians' ratings indicated that clients exhibited an average of 11.5 warning signs when they decompensated (range=0 to 27). Only 5 percent were rated as ...
  50. [50]
    SSA - POMS: DI 34132.011 - Mental Listings from 09/29/16 to 01/16/17
    Jan 13, 2017 · Episodes of decompensation are exacerbations or temporary increases in symptoms or signs accompanied by a loss of adaptive functioning, as ...
  51. [51]
    SSA's Disability Determination of Mental Impairments - NCBI - NIH
    repeated episodes of decompensation, each of extended duration. As an example, the SSA describes activities of daily living to include cleaning, shopping ...
  52. [52]
    Crisis Intervention - StatPearls - NCBI Bookshelf - NIH
    Crisis intervention is a short-term technique to reduce damage from overwhelming events, involving background info, relationship, discussion, and support.Missing: decompensation | Show results with:decompensation
  53. [53]
  54. [54]
    Cognitive behavioral therapy - Mayo Clinic
    Feb 26, 2025 · CBT can be a very helpful tool in treating many mental health conditions, such as depression, anxiety, post-traumatic stress disorder, also ...
  55. [55]
    Dialectical Behavioral Therapy for Adults with Mental Illness - NCBI
    Oct 20, 2017 · Emotion regulation skills include strategies for changing emotions and the tendency to respond with appropriate emotions. Distress tolerance ...
  56. [56]
    The role of selective serotonin reuptake inhibitors in preventing ...
    Nov 1, 2017 · This review provides evidence that continuing SSRIs for 1 year reduces risk of MDD and relapse. Furthermore, the combination of SSRIs and cognitive behavioural ...
  57. [57]
    Preventing Relapse of a Mental Illness - Here to Help BC
    When it comes to preventing relapse, there are three big parts to self-management: identifying your warning signs, taking action, and seeking outside help when ...